West Pharmaceutical Services Inc (WST) — Long-term Investment Intensity
West Pharmaceutical Services Inc (WST) has a Long-term Investment Intensity of 5.1% as of March 2026. Long-term investments of $209.20 Million represent 5.1% of total assets of $4.11 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check WST cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
West Pharmaceutical Services Inc Long-term Investment Intensity (2010–2025)
This chart shows how West Pharmaceutical Services Inc's Long-term Investment Intensity has evolved across 15 annual periods from 2010 to 2025. As of March 2026, the intensity stands at 5.1%, reflecting long-term investments of $209.20 Million against total assets of $4.11 Billion USD. Explore West Pharmaceutical Services Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for West Pharmaceutical Services Inc (2010–2025)
The table below presents the year-by-year Long-term Investment Intensity for West Pharmaceutical Services Inc from 2010 to 2025, covering 15 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see WST market cap overview.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 5.0% | $212.30 Million | $4.27 Billion | ▼ -0.6 pp |
| 2024 | 5.5% | $202.10 Million | $3.64 Billion | ▲ +0.1 pp |
| 2023 | 5.5% | $210.00 Million | $3.83 Billion | ▼ -0.2 pp |
| 2022 | 5.7% | $204.90 Million | $3.62 Billion | ▼ -0.6 pp |
| 2021 | 6.3% | $207.70 Million | $3.31 Billion | ▼ -1.4 pp |
| 2020 | 7.7% | $214.70 Million | $2.79 Billion | ▼ -0.5 pp |
| 2019 | 8.2% | $192.70 Million | $2.34 Billion | ▲ +2.5 pp |
| 2018 | 5.7% | $91.20 Million | $1.59 Billion | ▲ +1.1 pp |
| 2017 | 4.6% | $85.80 Million | $1.86 Billion | ▼ -0.2 pp |
| 2016 | 4.8% | $82.70 Million | $1.72 Billion | ▲ +1.2 pp |
| 2015 | 3.6% | $61.30 Million | $1.70 Billion | ▼ 0.0 pp |
| 2014 | 3.6% | $60.60 Million | $1.67 Billion | ▼ 0.0 pp |
| 2013 | 3.6% | $60.90 Million | $1.67 Billion | ▼ -0.2 pp |
| 2012 | 3.8% | $59.80 Million | $1.56 Billion | ▲ +0.1 pp |
| 2010 | 3.7% | $48.20 Million | $1.29 Billion | — |